GlassScriptPhysician profile
Eric C Zabat
NPI 1982637005
$2,678.65
in general payments reported to CMS, 2019-2025
33 companies · $306 in 2025
The $306 reported for 2025 was more than what 76% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $735 · 2020: $124 · 2021: $342 · 2022: $374 · 2023: $473 · 2024: $325 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,103.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $360.94 | 2019-2025 | Orthovisc, Monovisc |
| Zimmer Biomet Holdings, INC. | $255.46 | 2023-2024 | Gel-One Cross-Linked Hyaluronate |
| Pacira Pharmaceuticals Incorporated | $217.74 | 2022-2023 | Exparel |
| Ferring Pharmaceuticals INC. | $211.60 | 2019-2025 | Euflexxa |
| Mallinckrodt Enterprises LLC | $182.50 | 2019 | |
| Abbvie INC. | $162.02 | 2019-2020 | |
| Pacira Therapeutics, INC. | $153.42 | 2019-2021 | |
| Novo Nordisk INC | $125.01 | 2025 | Wegovy |
| Urgo Medical North America, LLC | $91.35 | 2022 | |
| Amgen INC. | $79.30 | 2019-2021 | |
| Heraeus Medical, LLC. | $75.17 | 2023-2024 | Palacos |
| Ucb, INC. | $74.91 | 2019-2020 | |
| Bioventus LLC | $70.41 | 2020-2022 | |
| Abbott Laboratories | $59.76 | 2024-2025 | Octrode |
| Hikma Pharmaceuticals USA | $54.29 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $50.21 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $49.35 | 2019-2023 | |
| Ibsa Pharma INC. | $48.71 | 2022-2023 | Licart, Tirosint |
| Tersera Therapeutics LLC | $44.25 | 2019 | |
| Smith+Nephew, INC. | $41.23 | 2022 | |
| Radius Health, INC. | $37.88 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $34.52 | 2024-2025 | |
| Kowa Pharmaceuticals America, INC. | $28.23 | 2023 | Seglentis |
| Stryker Corporation | $25.05 | 2023 | Omega, Alphavent, Inspace |
| Electronic Waveform Lab, INC. | $22.76 | 2023 | |
| Orthofix Medical, INC. | $20.27 | 2024 | Physio-Stim |
| Next Science LLC | $17.60 | 2021 | |
| Synergy Orthopedics, LLC | $17.32 | 2023 | |
| Sebela Pharmaceuticals INC. | $17.05 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $16.03 | 2021 | |
| Trevena, INC. | $13.49 | 2021 | |
| Djo, LLC | $12.76 | 2021 | |
| Fidia Pharma USA INC. | $8.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Zabat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.